Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 46–60 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5019
APCDD1 Gene Hypotrichosis Type 1 Genetic Test

This test analyzes the APCDD1 gene to detect pathogenic mutations associated with hereditary hypotrichosis simplex type 1.

Peripheral whole blood (3–5 mL) or dried blood spot on FTA card 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["APCDD1 gene mutations", "Copy Number Variants (CNVs) in APCDD1"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of hereditary hypotrichosis simplex type 1", "Carrier testing in at-risk relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94027-0 ICD-10: Q84.0
Clinical summary
This test analyzes the APCDD1 gene to detect pathogenic mutations associated with hereditary hypotrichosis simplex type 1.
TEST-6245
APOA5 Gene Hyperchylomicronemia Type 5 Genetic Test

This test identifies genetic mutations in the APOA5 gene associated with hyperchylomicronemia type 5, a severe lipid disorder.

Peripheral whole blood (EDTA tube), extracted DNA, or FTA card 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the APOA5 gene"]
Parameters
[]
Preparation
["Fasting is not required", "Inform phlebotomist of all medications and supplements"]
Indications
["Unexplained severe hypertriglyceridemia", "Recurrent pancreatitis", "Family history suggestive of familial hyperchylomicronemia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81293-3 ICD-10: E78.3
Clinical summary
This test identifies genetic mutations in the APOA5 gene associated with hyperchylomicronemia type 5, a severe lipid disorder.
TEST-6187
APOB Gene Hypobetalipoproteinemia Type 1 Genetic Test

This genetic test identifies pathogenic variants in the APOB gene associated with familial hypobetalipoproteinemia type 1.

Whole Blood, Extracted DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the APOB gene", "Lipid metabolism disorder risk"]
Parameters
[]
Preparation
["No fasting required", "Genetic counselling session required before testing"]
Indications
["Suspected familial hypobetalipoproteinemia type 1", "Family history of the disorder", "Evaluation of lipid metabolism disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94821-7 ICD-10: E78.6, Z83.49, E88.9
Clinical summary
This genetic test identifies pathogenic variants in the APOB gene associated with familial hypobetalipoproteinemia type 1.
TEST-6004
APOC2 Gene Apolipoprotein C-II Deficiency Genetic Test

This genetic test identifies pathogenic variants in the APOC2 gene associated with Apolipoprotein C-II deficiency.

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["APOC2 gene variants", "Pathogenic mutations"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any current medications"]
Indications
["Diagnosis of Apolipoprotein C-II deficiency", "Family cascade screening", "Differentiation from other hyperlipidemias"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48767-8 ICD-10: E78.1
Clinical summary
This genetic test identifies pathogenic variants in the APOC2 gene associated with Apolipoprotein C-II deficiency.
TEST-3819
APOL1 Gene Susceptibility to Focal Segmental Glomerulosclerosis Type 4 (FSGS4) Test

This genetic test identifies APOL1 risk variants (G1 and G2) associated with increased susceptibility to FSGS4 and end-stage kidney disease.

Peripheral whole blood (EDTA tube) 3–4 Weeks (includes post-test genetic counselling) 2,800.00 AED
View
View test specifications and preparation
What it measures
["APOL1 gene variants (G1 and G2)", "Genetic risk for FSGS4"]
Parameters
[]
Preparation
["No specific fasting required", "Avoid testing during acute febrile illness"]
Indications
["Individuals of African ancestry with proteinuria", "Unexplained CKD", "Family history of FSGS", "Collapsing glomerulopathy", "HIV-associated nephropathy", "Evaluation for kidney transplantation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81968-6 ICD-10: Z15.89, N04.1, Z84.1
Clinical summary
This genetic test identifies APOL1 risk variants (G1 and G2) associated with increased susceptibility to FSGS4 and end-stage kidney disease.
TEST-6062
APRT Gene Adenine Phosphoribosyltransferase Deficiency Genetic Test

This genetic test detects pathogenic variants in the APRT gene responsible for adenine phosphoribosyltransferase deficiency.

Whole Blood, FTA Card Spot, or Previously Extracted DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the APRT gene", "Single nucleotide variants", "Small insertions", "Small deletions"]
Parameters
[]
Preparation
["No fasting required", "Genetic counselling session mandatory before testing"]
Indications
["Suspected adenine phosphoribosyltransferase deficiency", "Recurrent 2,8-dihydroxyadenine kidney stones", "Chronic kidney disease of unknown origin"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E79.8
Clinical summary
This genetic test detects pathogenic variants in the APRT gene responsible for adenine phosphoribosyltransferase deficiency.
TEST-269
Aptamer Sequencing and Analysis Test

This test profiles synthetic aptamer libraries to identify high-affinity biomarkers relevant to oncology, rheumatology, and precision medicine.

Whole Blood (Peripheral) 8 weeks 4,000.00 AED
View
View test specifications and preparation
What it measures
["High-affinity biomarkers", "Synthetic oligonucleotide aptamer libraries"]
Parameters
[]
Preparation
["Do not discontinue prescribed medication without consulting your doctor."]
Indications
["Oncology biomarker discovery", "Rheumatology biomarker discovery", "Precision medicine applications"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51961-4 ICD-10: Z12.9
Clinical summary
This test profiles synthetic aptamer libraries to identify high-affinity biomarkers relevant to oncology, rheumatology, and precision medicine.
TEST-3928
AR Gene Androgen Insensitivity Genetic Test

This test evaluates the androgen receptor (AR) gene for mutations associated with androgen insensitivity syndrome (AIS). It identifies variants causing complete, partial, or mild f...

Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Mutations in the AR gene", "Point mutations", "Copy number variations"]
Parameters
[]
Preparation
["Provide a complete medication list at the time of sample collection.", "Do not discontinue or alter any prescribed medication without consulting your referring physician."]
Indications
["Diagnosis of Androgen Insensitivity Syndrome (AIS)", "Family planning for individuals with AIS", "Evaluation of ambiguous genitalia", "Investigation of infertility"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E34.5
Clinical summary
This test evaluates the androgen receptor (AR) gene for mutations associated with androgen insensitivity syndrome (AIS). It identifies variants causing complete, partial, or mild forms of AIS.
TEST-150
ATAC Sequencing Data Analysis Test

This test evaluates genome-wide open chromatin regions to identify regulatory elements influencing gene expression.

Whole Blood (EDTA) or High-Quality Extracted DNA (>100 ng) 4 Weeks (Guaranteed) 2,500.00 AED
View
View test specifications and preparation
What it measures
["Open chromatin regions", "Regulatory elements (promoters, enhancers)", "Transcription factor binding sites", "Differential accessibility"]
Parameters
[]
Preparation
["No fasting required", "Avoid strenuous exercise for 24 hours before collection", "No medication adjustments unless instructed by physician"]
Indications
["Precision oncology", "Rheumatology", "Complex disease research", "Identifying epigenetic drivers"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 80462-5 ICD-10: Z01.89
Clinical summary
This test evaluates genome-wide open chromatin regions to identify regulatory elements influencing gene expression.
TEST-229
ATAC Sequencing Test

This test evaluates genome-wide chromatin accessibility to identify regulatory elements.

Whole Blood (EDTA tube, 2–4 mL) or Extracted Genomic DNA (β‰₯2 Β΅g) 5 weeks 6,500.00 AED
View
View test specifications and preparation
What it measures
["Genome-wide open chromatin regions", "Regulatory elements", "Chromatin accessibility"]
Parameters
[]
Preparation
["No special preparation needed", "Avoid heparin-containing tubes if providing whole blood", "Stay hydrated"]
Indications
["Oncology research", "Precision medicine", "Biomarker discovery", "Epigenetic studies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 97926-7 ICD-10: Z01.89
Clinical summary
This test evaluates genome-wide chromatin accessibility to identify regulatory elements.
TEST-265
ATAC-Seq Analysis Test

This test evaluates genome-wide chromatin accessibility to identify open regulatory regions.

Whole Blood (Peripheral) or Extracted DNA 10 weeks 7,500.00 AED
View
View test specifications and preparation
What it measures
["Genome-wide nucleotide-level chromatin accessibility", "Open chromatin regions", "Active regulatory elements"]
Parameters
[]
Preparation
[]
Indications
["Oncology research", "Rheumatology research", "Translational research", "Identification of dysregulated chromatin regions in cancer and autoimmune diseases"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94222-8 ICD-10: Z13.9
Clinical summary
This test evaluates genome-wide chromatin accessibility to identify open regulatory regions.
TEST-3692
Ataxia Comprehensive Panel Genetic Test

This test evaluates for genetic mutations associated with various forms of hereditary ataxia.

Peripheral whole blood 3–4 Weeks 3,000.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medications without consulting your physician"]
Indications
["Patients presenting with progressive imbalance, slurred speech, and coordination difficulties", "Family screening for hereditary ataxia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: G11.9
Clinical summary
This test evaluates for genetic mutations associated with various forms of hereditary ataxia.
TEST-1844
Ataxia Gene Panel Test

This test evaluates over 200 genes associated with hereditary ataxias using Next-Generation Sequencing.

Peripheral whole blood or amniotic fluid 4–6 weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["Genetic variants in over 200 ataxia-associated genes", "Presence of pathogenic mutations"]
Parameters
[]
Preparation
["No drug or dietary supplement avoidance is needed prior to specimen collection."]
Indications
["Diagnosis of hereditary ataxia", "Family screening for ataxia risk", "Personalised management planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96534-4 ICD-10: G11.9
Clinical summary
This test evaluates over 200 genes associated with hereditary ataxias using Next-Generation Sequencing.
TEST-6216
AVPR2 Gene Nephrogenic Diabetes Insipidus, X‑linked Genetic Test

This test evaluates the entire coding region of the AVPR2 gene to identify mutations associated with X-linked nephrogenic diabetes insipidus.

Blood (EDTA), FTA Card, or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["AVPR2 gene sequence", "Single nucleotide variants", "Insertions", "Deletions", "Copy number changes"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication (e.g., thiazides, amiloride) without consulting your doctor."]
Indications
["Suspected X-linked nephrogenic diabetes insipidus", "Differentiation from central diabetes insipidus", "Guiding treatment planning", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81267-8 ICD-10: N25.1, Z13.79, Z84.89
Clinical summary
This test evaluates the entire coding region of the AVPR2 gene to identify mutations associated with X-linked nephrogenic diabetes insipidus.
TEST-542
Avuncular (Aunt/Uncle) DNA Relationship Test

This test evaluates the statistical probability of a biological aunt/uncle relationship using STR analysis.

Peripheral whole blood (EDTA tube) or buccal swab 10 Working Days (Expedited 7-day option available) 3,000.00 AED
View
View test specifications and preparation
What it measures
["Combined Relationship Index (CRI)", "Autosomal STR loci (21-27)", "Amelogenin markers"]
Parameters
[{"name": "Combined Relationship Index (CRI)", "reference_range": "β‰₯ 10,000:1 (Inclusion); < 0.001 (Exclusion)"}]
Preparation
["No specific fasting required", "Inform healthcare provider of recent blood transfusions or bone marrow transplants"]
Indications
["Establishing aunt/uncle relationship when parentage testing is unavailable", "Legal matters involving kinship", "Inheritance disputes", "Personal confirmation of relationship"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92804-3 ICD-10: Z13.79
Clinical summary
This test evaluates the statistical probability of a biological aunt/uncle relationship using STR analysis.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area